Prognos Health Company Profile

Background

Prognos Health is a healthcare technology company specializing in real-world data (RWD) analytics. Founded in 2010 and headquartered in New York City, the company is dedicated to unlocking the power of clinical and genomic laboratory data to improve health outcomes. By integrating and harmonizing extensive lab and health records, Prognos Health aims to accelerate the development and delivery of innovative therapies, particularly in the realms of rare diseases and oncology.

Key Strategic Focus

Prognos Health's strategic objectives include:

Data Integration and Harmonization: Combining diverse healthcare data sources to provide a comprehensive view of patient health.

Advanced Analytics: Utilizing machine learning and AI to derive actionable insights from complex datasets.

Targeted Healthcare Solutions: Offering precision marketing and patient journey analytics to pharmaceutical companies, payers, and providers.

Market Expansion: Extending services to international markets, with a primary focus on the United States, Germany, and the United Kingdom.

Financials and Funding

As of June 2025, Prognos Health has raised a total of $23 million in funding over five rounds. The latest funding round occurred on May 4, 2023, amounting to $23 million. The company's annual revenue is reported to be approximately $35 million.

Technological Platform and Innovation

Prognos Health's technological advancements include:

prognosFACTOR™: Launched in October 2020, this integrated platform unifies data across the healthcare landscape, enabling rapid cohort design and patient journey mapping. It allows clients to query over 30 billion lab records and 325 million de-identified patients, facilitating swift and flexible analytics.

healthLOGIC™: A proprietary technology that reduces query latency and enhances clinical specificity by providing immediate access to patient history without the need for extensive data scans.

Leadership Team

Sundeep Bhan: Co-Founder and Chief Executive Officer.

Jason Bhan, M.D.: Co-Founder and Chief Medical Information Officer.

Steve Chase: Chief Financial Officer.

Evan Closson: Chief Technology Officer.

Bill Paquin: Chief Commercial Officer.

Chris Hayes: Executive Vice President, General Manager of Sales and Business Development.

Patrick Ayseeh: Senior Vice President, Strategy.

Todd Somsel: Vice President, Real-World Data Marketplace.

Ashley Triscuit: Vice President, Marketing.

Competitor Profile

Market Insights and Dynamics:

The healthcare analytics market was valued at approximately $19.2 billion in 2021 and is projected to reach $50.5 billion by 2028, growing at a CAGR of 14.7%.

Key Competitors:

IQVIA: Holding an estimated 40% market share, IQVIA specializes in real-world data, clinical research, and healthcare analytics.

Syneos Health: With a 30% market share, Syneos focuses on clinical trials, commercialization, and patient engagement.

Parexel: Accounting for 15% of the market, Parexel offers services in drug development, regulatory affairs, and clinical research.

Strategic Collaborations and Partnerships

Prognos Health has established significant partnerships to enhance its data capabilities and market reach:

Labcorp Venture Fund: Participated as an investor, strengthening Prognos Health's position in the healthcare analytics sector.

Marshall Wace: A hedge fund that has invested in Prognos Health, supporting its growth and development.

Montage Capital: Provided debt financing to support Prognos Health's operational and strategic initiatives.

Operational Insights

Prognos Health's competitive advantages include:

Extensive Data Repository: Access to over 325 million de-identified patient records, providing a comprehensive dataset for analysis.

Advanced AI and Machine Learning: Utilization of proprietary technologies like healthLOGIC™ to deliver rapid and precise insights.

Strategic Partnerships: Collaborations with key industry players to enhance data quality and expand market reach.

Strategic Opportunities and Future Directions

Prognos Health is poised to capitalize on several strategic opportunities:

Expansion into New Therapeutic Areas: Broadening analytics services to cover additional medical conditions and specialties.

Development of AI-Driven Solutions: Enhancing predictive analytics capabilities to offer more personalized healthcare insights.

International Market Penetration: Extending services beyond the primary markets of the United States, Germany, and the United Kingdom to other regions.